R&D Excellence ALL ABOUT NEURAXPHARM About Neuraxpharm History Where we are Executive commitee Our commitment R&D Excellence Manufacturing International Trade Business Ethics and Compliance channel Neuraxpharm About Neuraxpharm R&D Excellence Neuraxpharm is a Research & Development company The wellbeing of those affected by central nervous system disorders is at the very heart of all we do. Our research and innovation efforts are dedicated to developing better, more adapted pharmaceutical forms and new therapeutic solutions to cater for the needs of those experiencing psychiatric and neurological disorders. Our patient-friendly products and formulations are developed in close consultation with medical specialists across Europe. + 0 YEARS CNS specialist finding solutions for disorders of CNS Expertise by experience Neuraxpharm has 35 years of specialist experience in finding solutions for disorders related to the central nervous system. The scientific work of our R&D service is led by our highly qualified and experienced team at Neuraxpharm Healthtech, our centre of excellence for innovation. Where science meets strategy Our R&D services provide expertise in: Intellectual property Development of active substances Development of pharmaceuticals Development and monitoring of bioequivalence studies Registrations of pharmaceutical specialities (regulatory affairs) Pharmacovigilance Dedication that breeds results The dedication of our R&D teams is reflected by the growing number of products supplied and distributed all over the world and by the loyalty of our clients. We are proud to be able to share some of our teams’ achievements: + 0 CNS Molecules + 0 k CNS SKUs 0 bn Units sold + 0 Inventions + 0 k Patents Worldwide + 0 Interventions generating more than 1.2k patents worldwide CNS Portfolio Neuraxpharm About us Our commitment Executive committee Neuraxpharm Blog Support Contact us Ethics and Compliance Channel Neuraxpharm @ 2021 Cookies policy Privacy policy Legal disclaimer Join our mailing list Get the latest updates from the Neuraxpharm.